Literature DB >> 22209772

NLRC5: a newly discovered MHC class I transactivator (CITA).

Torsten B Meissner1, Amy Li, Koichi S Kobayashi.   

Abstract

Major histocompatibility complex (MHC) class I and class II are crucial for the function of the human adaptive immune system. An NLR protein, CIITA (MHC class II transactivator), is a master regulator of MHC class II gene expression as well as of some of the genes involved in MHC class II antigen presentation. It has recently been discovered that another member of the NLR protein family, NLRC5, transcriptionally activates MHC class I genes, and thus acts as "CITA" (MHC class I transactivator), a counterpart to CIITA. In addition to MHC class I genes, NLRC5 can induce the expression of β2M, TAP1 and LMP2, essential components of MHC class I antigen presentation. These findings indicate that NLRC5 and CIITA are transcriptional regulators that orchestrate the concerted expression of critical components in the MHC class I and MHC class II pathways, respectively.
Copyright © 2011 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22209772      PMCID: PMC3323719          DOI: 10.1016/j.micinf.2011.12.007

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  67 in total

Review 1.  Genetic control of MHC class II expression.

Authors:  Jenny Pan-Yun Ting; John Trowsdale
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

2.  A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responses.

Authors:  Andreas Neerincx; Katja Lautz; Maureen Menning; Elisabeth Kremmer; Paola Zigrino; Marianna Hösel; Hildegard Büning; Robert Schwarzenbacher; Thomas A Kufer
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

Review 3.  Transcriptional regulation of the MHC class II antigen presentation pathway.

Authors:  Jeremy M Boss; Peter E Jensen
Journal:  Curr Opin Immunol       Date:  2003-02       Impact factor: 7.486

4.  NLRC5 limits the activation of inflammatory pathways.

Authors:  Szilvia Benko; Joao G Magalhaes; Dana J Philpott; Stephen E Girardin
Journal:  J Immunol       Date:  2010-07-07       Impact factor: 5.422

5.  NLRC5 deficiency does not influence cytokine induction by virus and bacteria infections.

Authors:  Himanshu Kumar; Surya Pandey; Jian Zou; Yutaro Kumagai; Ken Takahashi; Shizuo Akira; Taro Kawai
Journal:  J Immunol       Date:  2010-12-08       Impact factor: 5.422

Review 6.  All the peptides that fit: the beginning, the middle, and the end of the MHC class I antigen-processing pathway.

Authors:  Nilabh Shastri; Sylvain Cardinaud; Susan R Schwab; Thomas Serwold; Jun Kunisawa
Journal:  Immunol Rev       Date:  2005-10       Impact factor: 12.988

Review 7.  Regulation of MHC class II gene expression by the class II transactivator.

Authors:  Walter Reith; Salomé LeibundGut-Landmann; Jean-Marc Waldburger
Journal:  Nat Rev Immunol       Date:  2005-10       Impact factor: 53.106

Review 8.  AAA+ proteins: have engine, will work.

Authors:  Phyllis I Hanson; Sidney W Whiteheart
Journal:  Nat Rev Mol Cell Biol       Date:  2005-07       Impact factor: 94.444

9.  NLR family member NLRC5 is a transcriptional regulator of MHC class I genes.

Authors:  Torsten B Meissner; Amy Li; Amlan Biswas; Kyoung-Hee Lee; Yuen-Joyce Liu; Erkan Bayir; Dimitrios Iliopoulos; Peter J van den Elsen; Koichi S Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-16       Impact factor: 11.205

10.  The GTP-binding domain of class II transactivator regulates its nuclear export.

Authors:  Aparna Raval; Jocelyn D Weissman; T Kevin Howcroft; Dinah S Singer
Journal:  J Immunol       Date:  2003-01-15       Impact factor: 5.422

View more
  35 in total

1.  NLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens.

Authors:  Yikun Yao; Yalong Wang; Fuxiang Chen; Yin Huang; Shu Zhu; Qibin Leng; Hongyan Wang; Yufang Shi; Youcun Qian
Journal:  Cell Res       Date:  2012-04-10       Impact factor: 25.617

2.  Post-transcriptional inhibition of luciferase reporter assays by the Nod-like receptor proteins NLRX1 and NLRC3.

Authors:  Arthur Ling; Fraser Soares; David O Croitoru; Ivan Tattoli; Leticia A M Carneiro; Michele Boniotto; Szilvia Benko; Dana J Philpott; Stephen E Girardin
Journal:  J Biol Chem       Date:  2012-06-20       Impact factor: 5.157

3.  The nucleotide-binding domain of NLRC5 is critical for nuclear import and transactivation activity.

Authors:  Torsten B Meissner; Amy Li; Yuen-Joyce Liu; Etienne Gagnon; Koichi S Kobayashi
Journal:  Biochem Biophys Res Commun       Date:  2012-01-28       Impact factor: 3.575

Review 4.  NLRC5/CITA: A Key Player in Cancer Immune Surveillance.

Authors:  Sayuri Yoshihama; Saptha Vijayan; Tabasum Sidiq; Koichi S Kobayashi
Journal:  Trends Cancer       Date:  2017-01-10

5.  NLRC5/MHC class I transactivator is a target for immune evasion in cancer.

Authors:  Sayuri Yoshihama; Jason Roszik; Isaac Downs; Torsten B Meissner; Saptha Vijayan; Bjoern Chapuy; Tabasum Sidiq; Margaret A Shipp; Gregory A Lizee; Koichi S Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

6.  NLRP2 is a suppressor of NF-ƙB signaling and HLA-C expression in human trophoblasts†,‡.

Authors:  Tamara Tilburgs; Torsten B Meissner; Leonardo M R Ferreira; Arend Mulder; Kiran Musunuru; Junqiang Ye; Jack L Strominger
Journal:  Biol Reprod       Date:  2017-04-01       Impact factor: 4.285

7.  NLRC5 mediates cytokine secretion in RAW264.7 macrophages and modulated by the JAK2/STAT3 pathway.

Authors:  Lin Li; Tao Xu; Cheng Huang; Yunyun Peng; Jun Li
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

Review 8.  Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.

Authors:  Saptha Vijayan; Tabasum Sidiq; Suhail Yousuf; Peter J van den Elsen; Koichi S Kobayashi
Journal:  Immunogenetics       Date:  2019-01-31       Impact factor: 2.846

Review 9.  NLRP7 and related inflammasome activating pattern recognition receptors and their function in host defense and disease.

Authors:  Alexander D Radian; Lucia de Almeida; Andrea Dorfleutner; Christian Stehlik
Journal:  Microbes Infect       Date:  2013-04-22       Impact factor: 2.700

Review 10.  Alarmins, inflammasomes and immunity.

Authors:  Najwane Saïd-Sadier; David M Ojcius
Journal:  Biomed J       Date:  2012 Nov-Dec       Impact factor: 4.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.